TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy

Published:2023-04 Issue: Volume:178 Page:237-246
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hegedüs Luca,Okumus Özlem,Mairinger Fabian,Ploenes Till,Reuter Sebastian,Schuler Martin,Welt Anja,Vega-Rubin-de-Celis Silvia,Theegarten Dirk,Bankfalvi Agnes,Aigner Clemens,Hegedüs Balazs

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas;Mossman;Am J Pathol,2013

2. Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma;Metro;Hum Vaccin Immunother,2021

3. Irinotecan: 25 years of cancer treatment;Bailly;Pharmacol Res,2019

4. Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview;Kciuk;Int J Mol Sci,2020

5. Determinants of CPT-11 and SN-38 activities in human lung cancer cells;van Ark-Otte;Br J Cancer,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma;Lung Cancer;2023-11

2. Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR ^WT , EGFR ^T790M , and EGFR ^L858R );Journal of Enzyme Inhibition and Medicinal Chemistry;2023-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP